Literature DB >> 23035199

Use of clustered regularly interspaced short palindromic repeat sequence polymorphisms for specific detection of enterohemorrhagic Escherichia coli strains of serotypes O26:H11, O45:H2, O103:H2, O111:H8, O121:H19, O145:H28, and O157:H7 by real-time PCR.

Sabine Delannoy1, Lothar Beutin, Patrick Fach.   

Abstract

We explored the genetic diversity of the clustered regularly interspaced short palindromic repeat (CRISPR) regions of enterohemorrhagic Escherichia coli (EHEC) to design simplex real-time PCR assays for each of the seven most important EHEC serotypes worldwide. A panel of 958 E. coli strains investigated for their CRISPR loci by high-throughput real-time PCR showed that CRISPR polymorphisms in E. coli strongly correlated with both O:H serotypes and the presence of EHEC virulence factors (stx and eae genes). The CRISPR sequences chosen for simplex real-time PCR amplification of EHEC strains belonging to the top 7 EHEC serogroups differentiated clearly between EHEC and non-EHEC strains. Specificity estimates for the CRISPR PCR assays varied from 97.5% to 100%. Sensitivity estimates for the assays ranged from 95.7% to 100%. The assays targeting EHEC O145:H28, O103:H2, and O45:H2 displayed 100% sensitivity. The combined usage of two simplex PCR assays targeting different sequences of the O26 CRISPR locus allowed detection of EHEC O26:H11 with 100% sensitivity. By combining two simplex PCR assays targeting different sequences of the EHEC O157 CRISPR locus, EHEC O157:H7 was detected with 99.56% sensitivity. EHEC O111:H8 and EHEC O121:H19 were detected with 95.9% and 95.7% sensitivity, respectively. This study demonstrates that the identification of EHEC serotype-specific CRISPR sequences is more specific than the mere identification of O-antigen gene sequences, as is used in current PCR protocols for detection of EHEC strains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23035199      PMCID: PMC3503007          DOI: 10.1128/JCM.02097-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Identification of genes that are associated with DNA repeats in prokaryotes.

Authors:  Ruud Jansen; Jan D A van Embden; Wim Gaastra; Leo M Schouls
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

2.  Development of a method for the detection of verotoxin-producing Escherichia coli in food.

Authors:  Alexander Gill; Amalia Martinez-Perez; Sarah McIlwham; Burton Blais
Journal:  J Food Prot       Date:  2012-05       Impact factor: 2.077

3.  Identification of genetic markers for differentiation of Shiga toxin-producing, enteropathogenic, and avirulent strains of Escherichia coli O26.

Authors:  Marie Bugarel; Lothar Beutin; Flemming Scheutz; Estelle Loukiadis; Patrick Fach
Journal:  Appl Environ Microbiol       Date:  2011-02-11       Impact factor: 4.792

4.  Specific detection of enteroaggregative hemorrhagic Escherichia coli O104:H4 strains by use of the CRISPR locus as a target for a diagnostic real-time PCR.

Authors:  Sabine Delannoy; Lothar Beutin; Ylanna Burgos; Patrick Fach
Journal:  J Clin Microbiol       Date:  2012-08-15       Impact factor: 5.948

5.  CRISPR distribution within the Escherichia coli species is not suggestive of immunity-associated diversifying selection.

Authors:  Marie Touchon; Sophie Charpentier; Olivier Clermont; Eduardo P C Rocha; Erick Denamur; Catherine Branger
Journal:  J Bacteriol       Date:  2011-03-18       Impact factor: 3.490

6.  Real-time multiplex PCR for detecting Shiga toxin 2-producing Escherichia coli O104:H4 in human stools.

Authors:  Wenlan Zhang; Martina Bielaszewska; Andreas Bauwens; Angelika Fruth; Alexander Mellmann; Helge Karch
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

7.  Detection of Shiga toxin-producing Escherichia coli O26, O45, O103, O111, O113, O121, O145, and O157 serogroups by multiplex polymerase chain reaction of the wzx gene of the O-antigen gene cluster.

Authors:  Chitrita DebRoy; Elisabeth Roberts; Angela M Valadez; Edward G Dudley; Catherine N Cutter
Journal:  Foodborne Pathog Dis       Date:  2011-05       Impact factor: 3.171

8.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

Review 10.  Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.

Authors:  M M Levine
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

View more
  36 in total

1.  Association of clustered regularly interspaced short palindromic repeat (CRISPR) elements with specific serotypes and virulence potential of shiga toxin-producing Escherichia coli.

Authors:  Magaly Toro; Guojie Cao; Wenting Ju; Marc Allard; Rodolphe Barrangou; Shaohua Zhao; Eric Brown; Jianghong Meng
Journal:  Appl Environ Microbiol       Date:  2013-12-13       Impact factor: 4.792

2.  Genetic diversity and virulence potential of shiga toxin-producing Escherichia coli O113:H21 strains isolated from clinical, environmental, and food sources.

Authors:  Peter C H Feng; Sabine Delannoy; David W Lacher; Luis Fernando Dos Santos; Lothar Beutin; Patrick Fach; Marta Rivas; Elizabeth L Hartland; Adrienne W Paton; Beatriz E C Guth
Journal:  Appl Environ Microbiol       Date:  2014-05-23       Impact factor: 4.792

Review 3.  Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.

Authors:  P Gholizadeh; M Aghazadeh; M Asgharzadeh; H S Kafil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-11       Impact factor: 3.267

Review 4.  The role of CRISPR-Cas systems in virulence of pathogenic bacteria.

Authors:  Rogier Louwen; Raymond H J Staals; Hubert P Endtz; Peter van Baarlen; John van der Oost
Journal:  Microbiol Mol Biol Rev       Date:  2014-03       Impact factor: 11.056

5.  Discrimination of enterohemorrhagic Escherichia coli (EHEC) from non-EHEC strains based on detection of various combinations of type III effector genes.

Authors:  Sabine Delannoy; Lothar Beutin; Patrick Fach
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

6.  Towards a molecular definition of enterohemorrhagic Escherichia coli (EHEC): detection of genes located on O island 57 as markers to distinguish EHEC from closely related enteropathogenic E. coli strains.

Authors:  Sabine Delannoy; Lothar Beutin; Patrick Fach
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

Review 7.  CRISPR-based technologies: prokaryotic defense weapons repurposed.

Authors:  Rebecca M Terns; Michael P Terns
Journal:  Trends Genet       Date:  2014-02-18       Impact factor: 11.639

8.  CRISPRs of Enterococcus faecalis and E. hirae isolates from pig feces have species-specific repeats but share some common spacer sequences.

Authors:  Isha Katyal; Bonnie Chaban; Beata Ng; Janet E Hill
Journal:  Microb Ecol       Date:  2013-03-28       Impact factor: 4.552

9.  Subtyping of Salmonella enterica serovar Newport outbreak isolates by CRISPR-MVLST and determination of the relationship between CRISPR-MVLST and PFGE results.

Authors:  Nikki Shariat; Margaret K Kirchner; Carol H Sandt; Eija Trees; Rodolphe Barrangou; Edward G Dudley
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

10.  Polymorphism of CRISPR shows separated natural groupings of Shigella subtypes and evidence of horizontal transfer of CRISPR.

Authors:  Chaojie Yang; Peng Li; Wenli Su; Hao Li; Hongbo Liu; Guang Yang; Jing Xie; Shengjie Yi; Jian Wang; Xianyan Cui; Zhihao Wu; Ligui Wang; Rongzhang Hao; Leili Jia; Shaofu Qiu; Hongbin Song
Journal:  RNA Biol       Date:  2015-09-01       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.